Efficacy of tegoprazan‐based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double‐blind, active‐controlled study
Sign Up to like & getrecommendations! Published in 2023 at "Helicobacter"
DOI: 10.1111/hel.12977
Abstract: Bismuth‐based quadruple therapy (BQT) is recommended as the first‐line empirical therapy for Helicobacter pylori eradication as it is not associated with resistance. However, few studies have investigated the use of potassium‐competitive acid blockers for BQT. read more here.
Keywords: bismuth quadruple; quadruple therapy; therapy; helicobacter pylori ... See more keywords
Amoxicillin‐vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.15917
Abstract: The efficacy and safety of amoxicillin‐vonoprazan (VA) dual therapy remained unclear. read more here.
Keywords: vonoprazan dual; therapy helicobacter; dual therapy; amoxicillin vonoprazan ... See more keywords
Commentary: Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1090776
Abstract: Ma et al. (2022) published “Tailored therapy for Helicobacter pylori eradication,” a systematic review and meta-analysis suggesting that a tailored therapeutic approach might provide a better eradication success rate than empirical therapeutic methods in the… read more here.
Keywords: tailored therapy; therapy; eradication; treatment ... See more keywords